General Information: All chemicals were reagent grade and were used without further purification. Tetrahydrofuran was dried by heating under reflux over sodium wire in the presence of benzophenone as an indicator while dimethylformamide was dried by activated 3 Å molecular sieves. When necessary, the compounds were dried in vacuum over CaCl2. Reactions were monitored by Merck KGaA TLC silica gel plates (0.25 mm)( Kenilworth, NJ, USA) and visualized by 254 nm UV light, or by spraying with H2SO4-Ce(SO4)2. The derivatives 8 [67], 12a [45], 12b [65], and 12c [66] have been synthesized according to literature procedures. Proton 1H and carbon 13C nuclear magnetic resonance (NMR) experiments were recorded at 298K except when specified on Bruker Avance III HD 400 MHz, 500 MHz, or 600 MHz spectrometer (Billerica, MA, USA). Chemical shifts are reported relative to the residual solvent peak. A COSY spectrum was taken using a relaxation delay of 2 s with 30 scans and 170 increments of 2048 points each. HSQC spectra were performed with gradient selection, sensitivity enhancement, and phase sensitive mode using Echo/Antiecho-TPPI procedure. Optical rotations were measured at 589 nm (sodium lamp) and 20 °C on either a Perkin-Elmer 341 polarimeter (Waltham, MA, USA) or an Anton Paar MCP 200 polarimeter(Graz, Austria) with a path length of 1 dm. Infrared (IR) spectra were recorded neat on a Perkin–Elmer Spectrum Two FT-IR spectrometer. High-resolution (HRMS) electrospray ionization-time-of-flight (ESI-TOF) mass spectra were recorded on a Bruker micrOTOF® mass spectrometer.
Synthesis of derivatives 10 and 11: Cs2CO3 (1.25 equiv for each OH group) as added to a suspension of the appropriate calix[8]arene derivative 8 or 9 (1.0 g) in acetone (100 mL). The reaction mixture was stirred at reflux for 2 h. Then the system was cooled at room temperature and propargyl bromide (2.50 equiv for each OH group) was added. The reaction mixture was then stirred at reflux for 20 h, then it was cooled at room temperature and the solvent was removed under reduced pressure. An aqueous 1N solution of HCl (150 mL) was added to the reaction mixture and the suspension was stirred for 15 min. The aqueous phase was extracted and washed with CH2Cl2 (3 × 70 mL) and the organic phases were collected, dried over Na2SO4, filtered, and the solvent was removed under reduced pressure. The crude product was dissolved in a small amount of CH2Cl2 and then MeOH was added. The precipitated was filtered, affording the pure product as a white solid.
Compound 10: (76% yield); ESI(+) MS: m/z = 1603.1 [M + H]+, 1624.9 [M + Na]+; 1H NMR (400 MHz, CDCl3, 298 K): δ 1.11 (s, tBu, 72H), 2.30 (br t, 8H), 4.10 (s, 16H), 4.21 (d, J = 2.1 Hz, 16H), 6.95 (s, 16H) ppm; 13C NMR (100 MHz, CDCl3, 298K): δ 31.2, 31.5, 34.4, 60.9, 75.4, 79.7, 126.3, 133.4, 146.9, 153.1 ppm; Anal. calcd for C112H128O8: C, 83.96; H, 8.05; found C, 83.01; H, 8.16. Compound 11: (57% yield); ESI(+) MS: m/z = 1628.7 [M+H]+, 1647.9 [M+Na]+, 1667.9 [M+K]+; 1H NMR (600 MHz, CDCl3, 298K): δ 0.55 (s, 18H), 1.17 (s, 36H), 1.38 (s, 18H), 2.46 (br t, 4H), 2.56 (br t, 2H), 3.56 (s, 4H), 4.10 (s, 8H), 4.21 (s, 8H), 4.57 (s, 8H), 4.74 (s, 4H), 5.95 (s, 4H), 6.70 (s, 4H), 6.91 (s, 4H), 7.24 (br d, J = 2.2 Hz, 4H), 7.27 (s, 4H) ppm; 13C NMR (150 MHz, CDCl3, 298K): δ 31.0, 31.1, 31.6, 31.8, 34.0, 34.5, 60.6, 61.4, 75.2, 75.6, 80.0, 80.4, 124.6, 124.7, 126.3, 127.2, 128.3, 129.0, 132.4, 133.1, 133.6, 134.9, 136.43, 146.2, 146.4, 146.5, 151.5, 152.6, 154.4 ppm. Anal. calcd for C114H130O8: C, 84.09; H, 8.05; found C, 83.10; H, 8.14.
General procedure for the CuAAC with 12a and 12b: The calix[8]arene derivative 10 or 11 (10–15 mg) and the appropriate azide-armed DNJ iminosugar 12a or 12b (1.2 equiv for each alkyne unit) were dissolved in DMF (1.0 mL) in an ACE pressure tube. Then, a solution of Cu2SO4.5H2O (0.1 equiv. for each alkyne unit) and sodium ascorbate (0.2 equiv. for each alkyne unit) in water (0.25 mL) was added. The reaction mixture was heated under microwave irradiation for 20–30 min, using a CEM Corporation Discover LabMate system with the temperature controller. The mixture was concentrated, and traces of copper salts were removed by filtration through a short pad of silica gel eluting with CH3CN/AcOEt/NH4OH (9:1:1). The filtrate was concentrated and then purified by flash chromatography on silica gel.
Compound 13a: (AcOEt-AcOEt:MeOH 98:2, 51% yield; MS (ESI) m/z calcd for C272H384N32Na2O72 [M + 2Na]2+ 2648.3577; found 2648.3351; [α]D28 = +3.5 (c = 1, CHCl3); 1H NMR (300 MHz, CDCl3, 298K): δ 0.89 (s, 72H), 1.25 (br, 32H), 1.39 (br, 16H), 1.77 (br, 16H), 2.00–2.04 (m, 96H), 2.30 (t, J = 10.6 Hz, 8H), 2.53 (m, 8H), 2.61 (m, 8H), 2.70 (m, 8H), 3.16 (dd, J1 = 11.6 Hz, J2 = 4.9 Hz, 8H), 4.06 (s, 16H), 4.14 (br, 16H), 4.18 (overlapped, 16H), 4.79 (s, 16H), 4.92 (m, 8H), 5.03 (overlapped, 16H), 6.80 (s, 16H), 7.79 (s, 8H) ppm; 13C NMR (75 MHz, CDCl3, 298K): δ 20.9, 20.9, 21.1, 24.8, 26.6, 26.9, 30.2, 30.5, 31.4, 34.2, 50.2, 51.9, 53.1, 59.6, 61.6, 66.6, 69.6, 69.7, 74.9, 123.9, 126.1, 133.3, 144.1, 146.6, 152.7, 169.9, 170.2, 170.5, 171.0 ppm. Anal. calcd for C272H384N32O72: C, 62.18; H, 7.37; found C, 62.07; H, 7.48.
Compound 13b: (AcOEt:Petroleum Ether, 8:2, 52% yield); MS (ESI) m/z calcd for C296H432N32Na2O72 [M + 2Na]2+ 2816.5455; found 2816.5469; [α]D27 = +5.0 (c = 1, CHCl3); 1H NMR (600 MHz, CDCl3, 298K): δ 0.90 (s, 72H), 1.24 (overlapped, 80H), 1.39 (br, 16H), 1.76 (br, 16H), 2.00–2.06 (overlapped, 96H), 2.32 (t, J = 10.9 Hz, 8H), 2.55 (m, 8H), 2.62 (br d, J = 9.2 Hz, 8H), 2.70 (m, 8H), 3.17 (dd, J1 = 11.4 Hz, J2 = 5.1 Hz, 8H), 4.06 (s, 16H), 4.14 (br, 16H), 4.18 (br, 16H), 4.79 (s, 16H), 4.95 (m, 8H), 5.0–5.07 (overlapped, H3+H4, 16H), 6.80 (s, 16H), 7.78 (s, 8H) ppm; 13C NMR (150 MHz, CDCl3, 298 K): 20.9, 20.9, 21.1, 21.1, 24.8, 26.8, 27.5, 29.3, 29.7, 29.9, 30.6, 31.4, 34.2, 50.3, 52.1, 53.2, 59.7, 61.6, 66.6, 69.7, 69.7, 74.9, 123.9, 126.1, 133.3, 144.2, 146.6, 152.7, 170.0, 170.2, 170.6, 171.1 ppm. Anal. calcd for C296H432N32O72: C, 63.59; H, 7.79; found C, 63.50; H, 7.86.
Compound 14a: (AcOEt/Petroleum Ether 9:1-AcOEt, 51% yield); MS (ESI) m/z calcd for C234H322N24Na2O56 [M + 2Na]2+ 2205.1435; found 2205.1329; [α]D30 = +4.0 (c = 1, CHCl3); 1H NMR (600 MHz, CDCl3, 298K): δ 0.40 (s, 18H), 0.95–1.54 (overlapped, 44H), 1.17 (s, 36H), 1.41 (s, 18H), 1.86 (t, J = 7.2 Hz, 12H), 1.98–2.06 (overlapped, 72H), 2.25–2.30 (overlapped, 6H), 2.42–2.62 (overlapped, 14H), 2.69–2.74 (m, 4H), 3.10 (dd, J1 = 11.5 Hz, J2 = 5.2 Hz, 4H), 3.18 (dd, J1 = 11.5 Hz, J2 = 5.2 Hz, 2H), 3.32 (s, 4H), 3.44–3.48 (overlapped, 4H), 3.53 (m, 4H), 3.86–3.97 (overlapped, 8H), 4.07–4.17 (overlapped, 12H), 4.33 (t, J = 7.8 Hz, 4H), 4.36–4.40 (overlapped, 4H), 4.79 (d, J = 13.2 Hz, 4H), 4.89–4.96 (overlapped, 6H), 4.97–5.08 (overlapped, 12H), 5.82 (s, 4H), 6.58 (s, 2H), 6.61 (s, 2H), 6.95 (s, 2H), 6.98 (s, 2H), 7.22–7.28 (overlapped, 6H), 7.77 (s, 4H) ppm; 13C NMR (150 MHz, CDCl3, 298 K): δ 20.9, 21.0, 21.1, 24.4, 25.0, 26.5, 26.7, 26.8, 29.9, 30.3, 30.4, 30.6, 31.1, 31.6, 31.9, 33.9, 34.5, 34.5, 50.1, 50.4, 51.7, 51.9, 51.9, 53.1, 53.2, 59.4, 59.7, 61.5, 61.6, 61.9, 66.2, 67.0, 69.6, 69.7, 74.8, 75.0, 123.1, 123.3, 123.4, 124.0, 124.3, 127.3, 128.7, 129.2, 132.7, 133.4, 134.6, 134.7, 136.6, 144.0, 144.34, 146.5, 146.7, 152.4, 153.8, 169.9, 170.1, 170.3, 170.6, 171.1 ppm. Anal. calcd for C234H322N24O56: C, 64.36; H, 7.43; found C, 64.26; H, 7.51.
Compound 14b: (AcOEt/Petroleum Ether 72:28–AcOEt, 37% yield); MS (ESI) m/z calcd for C252H358N24Na2O56 [M + 2Na]2+ 2331.2844; found 2331.7650; [α]D31 = +7.5 (c = 1, CHCl3); 1H NMR (600 MHz, CDCl3, 298K): δ 0.41 (s, 18H), 1.05–1.30 (overlapped, 60H), 1.18 (s, 36H), 1.39 (s, 18H), 1.54 (br, 8H), 1.86 (br, 4H), 2.00–2.02 (overlapped, 72H), 2.29–2.34 (overlapped, 6H), 2.52–2.57 (overlapped, 6H), 2.61–2.64 (overlapped, 6H), 2.66–2.74 (overlapped, 6H), 3.14–3.20 (overlapped, 6H), 3.34 (s, H18, 4H), 3.43 (d, J = 14.4 Hz, 4H), 3.51 (d, J = 16.8 Hz, 4H), 3.89–3.99 (m, 8H), 4.10–4.17 (overlapped, 12H), 4.33 (t, J = 7.3 Hz, 4H), 4.39 (d, J = 16.6 Hz, 4H), 4.78 (d, J = 14.2 Hz, 4H), 4.92–4.97 (overlapped, 6H), 5.00–5.08 (overlapped, 24H), 5.84 (s, ArH, 4H), 6.60 (s, 4H), 6.96 (s, 4H), 7.24 (s, 4H), 7,26 (overlapped, 8H), 7.78 (s, 2H) ppm; 13C NMR (150 MHz, CDCl3, 298 K): δ 20.9, 21.0, 21.1, 21.2, 21.3, 22.9, 24.6, 24.9, 26.7, 26.7, 27.4, 27.5, 29.1, 29.2, 29.6, 29.7, 29.9, 30.1, 30.4, 30.6, 30.8, 31.1, 31.6, 31.8, 32.1, 33.9, 34.5, 50.3, 50.6, 52.0, 52.2, 53.2, 53.2, 59.7, 59.7, 60.6, 61.5, 61.7, 66.2, 67.1, 69.7, 69.7, 74.9, 75.0, 123.1,123.5, 124.0, 124.3, 127.3, 128.6, 129.2, 131.9, 132.8, 133.4, 134.7, 136.7, 144.2, 144.4, 145.9, 146.4, 146.5, 151.3, 152.4, 153.9, 169.9, 170.2, 170.2, 170.6, 171.1, 171.4 ppm. Anal. calcd for C252H358N24O56: C, 65.52; H, 7.81; found C, 65.43; H, 7.90.
General procedure for deacetylation of clusters 13a,b and 14a,b: The acetylated compound (10–15 mg) was dissolved in dry methanol (0.3–0.5 mL), and then NaOMe (0.45 equiv for each acetyl group) was added. The reaction mixture was stirred at room temperature for 6 h under nitrogen atmosphere. Methanol and water were added to dissolve the white precipitate. Dowex 50WX8-200 resin was added until pH=6–7 was reached. Then the solution was filtered and concentrated to give the pure compound.
Compound 6a: 67% yield; MS (ESI) m/z calcd for C208H320Na2O40 [M + 2Na]2+ 1676.1887; found 1976.1792; [α]D33= +13.0 (c = 0.067, MeOH); 1H NMR (600 MHz, MeOD, 298 K): δ 0.96 (s, 72H), 1.26–1.29 (overlapped, 32H), 1.50 (br, 16H), 1.73 (br, 16H), 2.31 (overlapped, 8H), 2.34 (overlapped, 8H), 2.68 (m, 8H), 2.88 (m, 8H), 3.08 (dd, J1 = 11.7 Hz, J2 = 5.04 Hz, 8H), 3.19 (t, J = 9 Hz, 8H), 3.40 (t, J = 9.2 Hz, 8H), 3.53 (m, 8H), 3.87 (br, 16H), 4.09 (s, 16H), 4.19 (br, 16H), 4.80 (br s, 16H), 6.89 (s, 16H), 7.96 (s, 8H), 8.51 (s, OH) ppm; 13C NMR (150 MHz, MeOD, 298 K): δ 25.1, 27.0, 27.5, 27.9, 28.2, 30.4, 30.5, 30.9, 31.3, 32.1, 33.2, 35.2, 36.6, 51.3, 53.9, 57.2, 58.7, 67.5, 70.2, 71.4, 80.1, 125.9, 131.0, 134.6, 145.2, 147.9, 154.1 ppm. Anal. calcd for C208H320N32O40: C, 63.91; H, 8.25; found C, 64.01; H, 8.16.
Compound 6b: 82% yield; MS (ESI) m/z calcd for C232H368N32Na2O40 [M + 2Na]2+ 2144.3765; found 2144.3665; [α]D27 = −4.0 (c = 0.24, MeOH); 1H NMR (600 MHz, MeOD, 313 K): δ 0.95 (s, 72H), 1.25 (overlapped, 80H), 1.57 (br, 16H), 1.76 (br, 16H), 2.46–2.49 (overlapped, 16H), 2.80 (m, 8H), 3.00 (m, 8H), 3.17 (dd, J1 = 11.3 Hz, J2 = 4.56 Hz, 8H), 3.23 (t, J = 9.1 Hz, 8H), 3.45 (t, J = 9.3 Hz, 8H), 3.57 (m, 8H), 3.87 (dd, J1 = 11.9 Hz, J2 = 2.5 Hz, 8H), 3.94 (dd, J1 = 12.1 Hz, J2 = 2.0 Hz, 8H), 4.07 (s, 16H), 4.21 (br, 16H), 4.81 (s, 16H), 6.88 (s, 16H), 7.96 (s, 8H), 8.43 (br s, 32H) ppm; 13C NMR (600 MHz, MeOD, 313 K): δ 25.0, 27.6, 28.2, 30.0, 30.3, 30.4, 30.5, 30.6, 30.7, 30.8, 31.2, 31.3, 31.9, 33.2, 35.1, 36.5, 49.8, 51.2, 53.9, 54.7, 56.6, 58.0, 67.4, 67.5, 69.6, 70.9, 79.6, 125.8, 127.2, 134.6, 145.2, 147.8, 154.0 ppm. Anal. calcd for C232H368N32O40: C, 65.63; H, 8.74; found C, 65.54; H, 8.84.
Compound 7a: 67% yield; MS (ESI) m/z calcd for C186H274N24Na2O32 [M + 2Na]2+ 1701.0168; found 1701.0117; [α]D29 = −2.0 (c = 1, MeOH); 1H NMR (600 MHz, MeOD, 298 K): δ 0.44 (s, 18H), 1.23 (s, 36H), 1.24–1.49 (overlapped, 44H), 1.48 (s, 18H), 1.81 (t, J = 7.2 Hz, 4H), 2.40–2.52 (overlapped, 12H), 2.68–2.75 (overlapped, 6H), 2.87–2.97 (overlapped, 6H), 3.11–3.16 (overlapped, 6H), 3.20–3.24 (overlapped, 6H), 3.36 (s, 4H), 3.40–3.46 (overlapped, 6H), 3.52–3.58 (overlapped, 6H), 3.60–3.65 (overlapped, 8H), 3.82–3.94 (overlapped, 20H), 4.37–4.42 (overlapped, 8H), 4.89–4.96 (overlapped, 8H), 5.15 (br s, 8H), 5.86 (s, 4H), 6.67 (s, 4H), 7.05 (d, J = 7.2 Hz, 4H), 7.36 (s, 4H), 7.39 (s, 4H), 7.42 (s, 4H), 8.28 (s, 2H), 8.44 (br s, OH) ppm; 13C NMR (150 MHz, MeOD, 298 K): δ 23.7, 24.5, 24.5, 24.7, 27.2, 27.27, 27.6, 30.3,30.5, 30.6, 30.7, 31.0, 31.1, 31.2, 31.9, 32.0, 32.2, 33.1, 34.9, 35.3, 35.6, 51.3, 51.3, 53.7, 53.7, 56.4, 56.5, 56.7, 57.5, 58.1, 66.7, 67.3, 67.4, 67.5, 69.4, 69.5, 69.7, 70.6, 71.0, 76.2, 79.5, 79.6, 79.7, 125.0, 126.0, 126.1, 128.7, 129.8, 130.3, 133.2, 133.2, 134.1, 134.9, 135.4, 137.7, 145.1, 145.1, 145.3, 147.1, 148.0, 148.1, 152.57, 153.5, 153.5, 154.8 ppm. Anal. calcd for C186H274N24O32: C, 66.52; H, 8.22; found C, 66.62; H, 8.12.
Compound 7b: 80% yield; MS (ESI) m/z calcd for C204H310N24Na2O32 [M + 2Na]2+ 1827.1576; found 1827.1540; [α]D29 = −4.0 (c = 1, MeOH); 1H NMR (600 MHz, MeOD, 298 K): δ 0.45 (s, 18H), 1.03–1.29 (overlapped, 60H), 1.22 (s, 36H), 1.45 (s, 18H), 1.48–1.56 (overlapped, 20H), 1.83 (m, 4H), 2.35–2.45 (overlapped, 12H), 2.71–2.78 (overlapped, 6H), 2.90–2.96 (overlapped, 6H), 3.09–3.14 (overlapped, 6H), 3.38 (s, 4H), 3.40–3.45 (overlapped, 6H), 3.50–3.56 (overlapped, 14H), 3.85–3.97 (overlapped, 20H), 4.36–4.42 (overlapped, 8H), 4.87–4.92 (overlapped, 8H), 5.11 (d, J = 12 Hz, 4H), 5.16 (s, 4H), 5.89 (s, 4H), 6.67 (s, 4H), 7.02 (s, 4H), 7.35 (s, 4H), 7.36 (s, 4H), 7.40 (s, 4H), 8.25 (s, 2H), 8.50 (br s, OH) ppm; 13C NMR (150 MHz, MeOD, 298 K): δ 23.7, 25.0, 25.2, 27.4, 27.5, 28.3, 29.8, 29.9, 30.2, 30.4, 30.7, 31.1, 31.3, 31.4, 31.7, 31.9, 32.0, 32.2, 34.8, 35.3, 35.3, 51.4, 53.9, 54.8, 56.9, 57.0, 58.3, 58.6, 66.8, 67.4, 67.5, 69.9, 70.0, 71.2, 71.3, 79.8, 79.9, 125.1, 125.3, 126.0, 128.7, 129.7, 130.3, 133.3, 134.1, 134.8, 135.6, 137.9, 145.2, 147.1, 147.8, 147.9, 152.5, 153.6, 154.9 ppm. Anal. calcd for C204H310N24O32: C, 67.86; H, 8.65; found C, 67.97; H, 8.56.
General Procedure for the CuAAC Reaction with trivalent dendron 12c: The calix[8]arene derivative 10 or 11 (10–15 mg) and the derivative 12c (1.2 equiv. for each alkyne unit) were dissolved in DMF (1.0 mL) in an ACE pressure tube. Then, a solution of Cu2SO4.5H2O (0.1 equiv. for each alkyne unit) and sodium ascorbate (0.2 equiv. for each alkyne unit) in water (0.25 mL) was added. The resulting suspension was heated under microwave irradiation at 80 °C for 30 min, then water (10 mL) was added, and the aqueous phase was extracted with EtOAc (3 × 12 mL). The organic phases were combined, dried with Na2SO4, and concentrated in vacuo. Traces of copper salts were removed by filtration through a short pad of silica gel eluting with CH3CN/H2O/NH4OH (15:0.5:0.5), and the residue was then purified by flash chromatography (SiO2; CH2Cl2/MeOH, 99:1 to 95:5) to give the desired iminosugar.
Compound 13c: 66% yield; [α]D20 = +3.5 (c = 1, MeOH); 1H NMR (CDCl3, 400 MHz): δ 7.85 (br s, 8H), 7.57 (s, 24H), 6.8 (br s, 16H), 5.10–4.99 (m, 48H), 4.98–4.91 (m, 24H), 4.81 (br s, 53H), 4.51 (s, 48H), 4.41 (br s, 10H), 4.33–4.27 (t, J = 7.4 Hz, 48H), 4.14 (s, 48H), 4.03 (br s, 92H), 3.52–3.36 (m, 96H), 3.21–3.15 (dd, J1 = 11.4, J2 = 5.0 Hz, 24H), 2.76–2.66 (m, 24H), 2.65–2.60 (m, 24H), 2.59–2.50 (m, 24H), 2.35–2.28 (dd, J1 = 10.9, J2=10.5 Hz, 24H), 2.06 (s, 72H), 2.02–1.99 (overlapped, 216H), 1.90–1.84 (m, 48H,), 1.46–1.16 (288H), 0.97–0.72 (m, 72H) ppm; 13C-NMR (CDCl3, 100 MHz): δ 171.0, 170.4, 170.1, 169.9, 145.3, 122.6, 74.9, 70.4–69.8, 69.7, 69.6, 69.4, 65.2, 61.6, 59.7, 53.1, 51.9, 50.4, 50.1, 45.5, 31.3, 30.5, 29.6, 29.2, 27.3, 26.7, 24.9, 21.0, 21.0, 20.9, 20.8 ppm; IR (neat) 1745 cm−1; MS (ESI, deconvoluted): m/z calcd for C808H1249N120O240 [M + 10H]10+ 1648.4740; found 1648.4710.
Compound 14c: 48% yield; [α]D20 = + 4.5 (c = 1, MeOH); 1H NMR (CDCl3, 400 MHz, 298K): δ 8.11–7.59 (m, 57H), 7.61–7.50 (m, 18H), 7.38–7.16 (m, 8H), 6.96–6.58 (m, 4H), 6.58 (s, 4H), 5.89–5.73 (m, 4H), 5.16–4.99 (m, 48H), 4.99–4.91 (m, 18H), 4.89–4.63 (m, 9H), 4.61–4.44 (m, 42H), 4.36–4.22 (m, 42H), 4.14 (s, 36H), 3.91–3.80 (m, 4H), 3.78–3.63 (m, 8H), 3.54–3.31 (m, 72H), 3.21–3.15 (dd, J1 = 11.5 and J2 =4.9 Hz, 18H), 2.76–2.66 (m, 18H), 265–2.60 (m, 18H), 2.59–2.49 (m, 18H), 2.35–2.28 (t, J = 10Hz, 18H), 2.09–2.04 (s, 54H), 2.03–2.00 (s, 108H), 2.01–1.98 (s, 54H), 1.93–1.79 (m, 36H), 1.49–1.10 (m, 270H), 0.37 (s, 18H) ppm; 13C NMR (CDCl3, 75 MHz, 298 K): δ 170.9, 170.4, 170.1, 169.8, 162.6, 145.42, 145.37, 144.2, 122.62, 122.53, 74.9, 69.8, 69.6, 69.5, 68.1, 65.2, 61.7, 59.8, 53.1, 52.0, 51.9, 50.4, 50.4, 45.6, 45.5, 36.6, 34.4, 34.4, 31.8, 31.6, 31.5, 31.1, 30.5, 29.6, 29.2, 27.4, 26.7, 25.8, 25.1, 25.0, 20.97, 20.94, 20.85, 20.80 ppm; MS (ESI, deconvoluted) m/z calcd for C636H978N90O182 [M + 14H]14+ 913.8864; found 913.9960.
General procedure for the deacetylation reaction of 13c and 14c: Amberlite resin IRA 400 (6n g/mmol of substrate; n = number of acetate groups) was added to a solution of acetylated iminosugar in a mixture of MeOH/H2O (1:1), and the resulting solution was stirred for 4 h by using a rotary evaporator at atmospheric pressure. The resin was then removed by filtration and washed with methanol and water. Solvents were evaporated under reduced pressure to give the desired deprotected iminosugar.
Compound 6c: 89% yield; [α]D20 =−2.5 (c = 1, MeOH); 1H NMR (MeOD, 400 MHz, 298K): δ 8.22–7.99 (br s, 8H), 7.97–7.82 (s, 24H), 7.19–6.59 (br s, 16H), 4.57–4.42 (m, 64H), 4.41–4.28 (m, 48H), 3.84 (s, 48H), 3.54–3.32 (overlapped, 64H), 3.20–3.07 (m, 24H,), 3.01–2.94 (dd, J1 = 11.9, J2 = 5.5 Hz, 24H), 2.83–2.71 (m, 24H), 2.62–2.50 (m, 24H), 2.20–2.12 (dd, J1 = 11.9, J2 = 11.5 Hz, 24H), 2.12–2.07 (m, 24H), 1.94–1.79 (m, 48H), 1.55–1.38 (m, 48H), 1.39–1.17 (m, 240H), 0.99–0.79 (m, 72H) ppm; 13C-NMR (MeOD, 100 MHz, 298K) δ 146.2, 124.9, 80.6, 72.1, 70.8, 67.4, 65.5, 59.6, 57.8, 53.8, 51.4, 32.1, 31.4, 30.6, 30.1, 28.6, 27.6, 25.3 ppm; IR (neat) 3356 (broad strong OH) cm−1; MS (ESI, deconvoluted) m/z calcd for C616H1058N120O144 [M + 10H]10+ 1244.9054; found 1244.9090.
Compound 7c: 96% yield; [α]D20 =−5.0 (c = 1, MeOH/H2O 1:1); 1H NMR (MeOD, 500 MHz, 298K): δ 8.33 (s, 2H), 7.99–7.85 (several s, 18H), 7.69 (several s, 4H), 7.41–7.20 (m, 8H), 6.96 (s, 4H), 6.80–6.55 (m, 4H), 5.95–5.81 (m, 4H), 5.21–4.98 (m, 12H), 4.64 (m, 4H), 4.54–4.25 (m, 88H), 3.84 (m, 40H), 3.73–3.58 (m, 8H), 3.54–3.22 (m, 120H), 3.13 (t, J = 9.0 Hz, 18H), 2.97 (dd, J = 11.2 and 5.1 Hz, 18H), 2.82–2.72 (m, 18H), 2.61–2.51 (m, 18H), 2.16 (dd, J = 11.1 and 10.0 Hz, 18H), 2.10 (m, 18H), 1.90–1.77 (m, 36H), 1.51–1.19 (m, 270H), 0.43 (s, 18H) ppm; 13C-NMR (MeOD, 125 MHz, 20480 scans) δ 155.0, 153.5, 152.4, 147.8, 147.5, 146.8, 146.1, 145.3, 145.1, 137.9, 135.8, 135.0, 134.2, 133.6, 133.3, 132.4, 130.4, 129.86, 129.8, 129.5, 128.8, 126.9, 126.8, 125.9, 125.2, 124.9, 80.6, 76.2, 72.0, 70.8, 71.3, 71.2, 70.3, 70.11, 69.99, 69.08, 67.3, 65.51, 65.46, 59.5, 57.8, 53.8, 51.3, 46.53, 46.50, 35.4, 35.3, 34.9, 32.3, 32.2, 32.0, 31.4, 30.6, 30.1, 28.6, 27.5, 25.2) ppm. IR (neat) 3338 (broad strong OH) cm−1. MS (ESI) m/z calcd for C492H830N90O110 [M + 10H]10+ 976.6409; found 976.6068.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.